Skip to main content

Quality-of-life outcomes and osteoarthritis development at 10-years after anterior cruciate ligament reconstruction: A large randomized clinical trial comparing patellar tendon, hamstring tendon and double-bundle grafts

In brief

Patellar tendon ACL graft cuts traumatic re-injury to 8% vs 22% with hamstring

In this 10-year randomized trial of 330 patients, all three graft types yielded similar quality-of-life scores, but patellar-tendon grafts had a markedly lower rate of traumatic re-injury (8% versus about 22% for both single- and double-bundle hamstring grafts). However, the patellar-tendon group experienced twice as many lateral osteoarthritis changes. The trade-off between durability and joint wear remains unresolved.

Journal
Journal of ISAKOS : joint disorders & orthopaedic sports medicine (Q1)
Published
19 September 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Nicholas Mohtadi, Denise Chan, Dana Hunter, Pablo Bertiche, Hana Marmura, Dianne Bryant
PMID
42762953
DOI
10.1016/j.jisako.2026.101220

Why clinicians should know about it

Abstract

INTRODUCTION: This large randomized clinical trial compared disease-specific quality-of-life, clinical and radiographic outcomes 10-years following Anterior Cruciate Ligament (ACL) reconstruction with patellar tendon (PT), single-bundle (HT; quadruple-stranded semitendinosis-gracilis/tendons), or double-bundle (DB; 2-stranded semitendinosis and 2-stranded gracilis tendon) hamstring tendon constructs. METHODS: Three-hundred-and-thirty ACL deficient patients (183 males; 14-50 years) were randomized to PT (n=110, mean 28.7 years), single-bundle HT (n=110, mean 28.5 years), or double-bundle DB, (n=110, mean 28.3 years). An independent assessor and patients were blinded to treatment allocation up to 2-years. Outcomes were assessed at Baseline, 2-, 5- and 10-years post-operatively. PRIMARY OUTCOME: ACL Quality-of-Life (ACL-QOL) score. SECONDARY OUTCOMES: pivot shift, kneeling pain, International Knee Documentation Committee (IKDC) scores, Tegner Activity Level, traumatic re-injuries and contralateral ACL tears. A blinded assessor graded each knee compartment using the International Knee Documentation Committee (IKDC) radiographic scale. RESULTS: Two-hundred-and-eighty-seven patients (87%) completed 10-year follow-up (mean 10.2 1.2 years). Mean ACL-QOL scores increased over time for all groups (p<0.001), with no statistically significant difference at 10-years (PT=76.4 21.0 (95%CI 72.1-80.7); HT=77.7 20.5 (95%CI 73.4-81.9); DB=77.3 21.5 (95%CI 73.0-81.7); p=0.912). Fewer traumatic re-injuries occurred with PT grafts (PT=8%; HT=22%; DB=21%, p=0.023). No statistically significant differences for contralateral ACL tears (PT=13%; HT=13%; DB=10%; p=0.801), kneeling pain (PT=6%; HT=4%; DB=7%; p=0.637), Normal/Nearly Normal IKDC Objective scores (PT=73%; HT=68%; DB=72%; p=0.724) or the remaining secondary outcomes. Pivot shift grade ≥2 was less likely with a PT reconstruction (PT=18%; HT=25%; DB=24%; p=0.584). Forty-five percent of patients had radiographic OA at 10-year follow-up (medial=17%; lateral=29%; patellofemoral=6%). ACL-QOL scores were statistically significantly lower for patients with medial (69.3 3.2) and lateral OA (72.8 2.4). The PT group had more lateral OA (PT=42%, HT=23%, DB=23%; p=0.010), but no statistically significant differences in medial (PT=14%, HT=12%, DB=24%, p=0.094) or patellofemoral OA (PT=5%, HT=7%, DB=8%, p=0.782). Contributors of medial OA included baseline age, medial meniscectomy, chondral damage and subsequent secondary surgery. Contributors of lateral OA included PT graft, valgus alignment and lateral meniscectomy. ConclusionsACL reconstructive surgery consistently improves quality-of-life, with most patients remaining highly active at 10 years. ACL-QOL scores were lower for patients with medial and lateral OA. More traumatic re-injuries occurred with HT and DB reconstructions. PT reconstructions were more likely to have lateral radiographic changes. All effect sizes demonstrating these associations were small. LEVEL OF EVIDENCE: Level 1 CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov # ID number.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.